BE902626A - Nouvelle forme galeinique retard. - Google Patents

Nouvelle forme galeinique retard.

Info

Publication number
BE902626A
BE902626A BE1/011271A BE1011271A BE902626A BE 902626 A BE902626 A BE 902626A BE 1/011271 A BE1/011271 A BE 1/011271A BE 1011271 A BE1011271 A BE 1011271A BE 902626 A BE902626 A BE 902626A
Authority
BE
Belgium
Prior art keywords
matrix
galeinic
water
agent
new delayed
Prior art date
Application number
BE1/011271A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE902626A publication Critical patent/BE902626A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE1/011271A 1984-06-14 1985-06-10 Nouvelle forme galeinique retard. BE902626A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (1)

Publication Number Publication Date
BE902626A true BE902626A (fr) 1985-12-10

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011271A BE902626A (fr) 1984-06-14 1985-06-10 Nouvelle forme galeinique retard.

Country Status (21)

Country Link
AT (1) AT391806B (cs)
AU (2) AU587190B2 (cs)
BE (1) BE902626A (cs)
CA (1) CA1264441A (cs)
CY (1) CY1635A (cs)
DE (1) DE3520184C2 (cs)
DK (1) DK167649B1 (cs)
ES (1) ES8702141A1 (cs)
FR (1) FR2565822B1 (cs)
GB (3) GB2160100B (cs)
GR (1) GR851430B (cs)
HK (1) HK25192A (cs)
HU (1) HU198844B (cs)
IE (1) IE58834B1 (cs)
IL (1) IL75490A0 (cs)
IT (1) IT1200080B (cs)
LU (1) LU85946A1 (cs)
NL (1) NL194389C (cs)
NZ (1) NZ212390A (cs)
PT (1) PT80635B (cs)
SE (1) SE504583C2 (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
ATE417604T1 (de) 1996-07-08 2009-01-15 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
AU5483600A (en) * 1999-06-11 2001-01-02 Jean A. Chmielewski Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
RU2220715C2 (ru) * 1999-08-04 2004-01-10 Яманоути Фармасьютикал Ко., Лтд. Стабильная пероральная, образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
WO2002064118A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified release formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (de) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
WO2010022193A2 (en) * 2008-08-20 2010-02-25 Board Of Regents, The University Of Texas System Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
SE442265B (sv) * 1978-12-21 1985-12-16 Sandoz Ag Fast, enteral-overdragen komposition i enhetsform for oral tillforsel innehallande en ergotalkaloid
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
DK264785A (da) 1985-12-15
PT80635A (en) 1985-07-01
DK167649B1 (da) 1993-12-06
IL75490A0 (en) 1985-10-31
GB2196852B (en) 1989-05-17
DK264785D0 (da) 1985-06-12
AU4454389A (en) 1990-03-22
ATA174885A (de) 1990-06-15
IE58834B1 (en) 1993-11-17
HUT40918A (en) 1987-03-30
IT8548210A0 (it) 1985-06-13
SE504583C2 (sv) 1997-03-10
FR2565822B1 (fr) 1989-02-17
PT80635B (pt) 1987-10-20
SE8502950L (sv) 1985-12-15
DE3520184A1 (de) 1985-12-19
GR851430B (cs) 1985-11-25
NL194389B (nl) 2001-11-01
HU198844B (en) 1989-12-28
ES544075A0 (es) 1987-01-01
GB2196851A (en) 1988-05-11
GB2160100A (en) 1985-12-18
HK25192A (en) 1992-04-10
DE3520184C2 (de) 1997-03-13
GB2160100B (en) 1989-06-01
IE851460L (en) 1985-12-14
AU4348685A (en) 1985-12-19
GB2196851B (en) 1989-06-07
AU587190B2 (en) 1989-08-10
AT391806B (de) 1990-12-10
ES8702141A1 (es) 1987-01-01
GB8514855D0 (en) 1985-07-17
NL194389C (nl) 2002-03-04
NL8501578A (nl) 1986-01-02
GB8727055D0 (en) 1987-12-23
GB2196852A (en) 1988-05-11
FR2565822A1 (fr) 1985-12-20
LU85946A1 (fr) 1986-01-24
CY1635A (en) 1992-11-06
CA1264441A (en) 1990-01-16
NZ212390A (en) 1992-02-25
SE8502950D0 (sv) 1985-06-13
IT1200080B (it) 1989-01-05
GB8727056D0 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
BE902626A (fr) Nouvelle forme galeinique retard.
KR840000236A (ko) 포유류의 국부용 제형의 수분 손실량을 극소화시키는 방법
IE39898B1 (en) 1-or 7-oxoalkyl xanthine derivatives
ATE60922T1 (de) Zusammensetzungen fuer die kesselsteinverhuetung.
FR2426731A1 (fr) Compositions tensio-actives aqueuses et concentrees
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
ES461077A1 (es) Procedimiento para la preparacion de 2-bencilpirrolidinas.
DK287282A (da) Fremgangsmaade til fremstilling af adamantylethylaminer
JPS5371111A (en) Detergent composition
DE3277731D1 (en) Solid, strong alcaline compounds that contain active chlorine
MY101902A (en) Novel galenical retard form
JPS51146422A (en) Preparation of sulfochloride
GB722202A (en) Improvements in lagging members for mine galleries and the like
Rastogi et al. Nucleic acid and protein content of the frog pars distalis and hypothalamus during the annual reproductive cycle
JPS57185219A (en) Remedy for cancer
ES8500897A1 (es) Un procedimiento para la preparacion de una composicion de oxido de amina.
Shelaev Reduction of the End Waste When Manufacturing Rectangular Forgings
JPS52120911A (en) Prevention of crack at grain boundary at high temperature
JPS5224189A (en) Recovery of aluminum compound from aluminum-sludge including iron
Cheesewright EEC Steel Output Rises Only 1% in First Half of Year.(1985)
Shmurygina et al. The Formation and Behavior of Fluoroaluminates of Alkaline and Alkaline-Earth Metals in Zinc Sulfate Solutions
JPS5337664A (en) Preparation of 5-benzylhydantion
TANAKA et al. Effects of Some Food Additives on Protein Biosynthesis by Rat Liver Slice and Cell-Free System (Part 2)
JPS5297909A (en) Preparation of perfluoroacrylic acid derivatives
Hilgenfeldt et al. Some Aspects of the Increased Use of Secondary Aluminum Alloys for Pressure Die Casting

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050610

RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20050610